Abstract:Two recently engineered SpCas9 variants, namely xCas9 and Cas9-NG, show promising potential in improving targeting specificity and broadening the targeting range. In this study, we evaluated these Cas9 variants in the model and crop plant, rice. We first tested xCas9-3.7, the most effective xCas9 variant in mammalian cells, for targeted mutagenesis at 16 possible NGN PAM (protospacer adjacent motif) combinations in duplicates. xCas9 exhibited nearly equivalent editing efficiency to wild-type Cas9 (Cas9-WT) at most canonical NGG PAM sites tested, whereas it showed limited activity at non-canonical NGH (H = A, C, T) PAM sites. High editing efficiency of xCas9 at NGG PAMs was further demonstrated with C to T base editing by both rAPOBEC1 and PmCDA1 cytidine deaminases. With mismatched sgRNAs, we found that xCas9 had improved targeting specificity over the Cas9-WT. Furthermore, we tested two Cas9-NG variants, Cas9-NGv1 and Cas9-NG, for targeting NGN PAMs. Both Cas9-NG variants showed higher editing efficiency at most non-canonical NG PAM sites tested, and enabled much more efficient editing than xCas9 at AT-rich PAM sites such as GAT, GAA, and CAA. Nevertheless, we found that Cas9-NG variants showed significant reduced activity at the canonical NGG PAM sites. In stable transgenic rice lines, we demonstrated that Cas9-NG had much higher editing efficiency than Cas9-NGv1 and xCas9 at NG PAM sites. To expand the base-editing scope, we developed an efficient C to T base-editing system by making fusion of Cas9-NG nickase (D10A version), PmCDA1, and UGI. Taken together, our work benchmarked xCas9 as a high-fidelity nuclease for targeting canonical NGG PAMs and Cas9-NG as a preferred variant for targeting relaxed PAMs for plant genome editing.

Characterization of Brevibacillus Laterosporus Cas9 (blatcas9) for Mammalian Genome Editing

Structure and engineering of Brevibacillus laterosporus Cas9

Genome editing with natural and engineered CjCas9 orthologs

Characterization of NiCas12b for in Vivo Genome Editing.

In vivo genome editing using Staphylococcus aureus Cas9

CRISPR-Cas12a System With Synergistic Phage Recombination Proteins for Multiplex Precision Editing in Human Cells

Discovery and Engineering of a New BvCas12a Nuclease for Mammalian Genome Editing and Nucleic Acid Detection

Discovery and engineering of small SlugCas9 with broad targeting range and high specificity and activity

Cas9-orthologue-mediated cytosine and adenine base editors recognizing NNAAAA PAM sequences

Compact SchCas9 Recognizes the Simple NNGR PAM

Genome Editing in Zebrafish by ScCas9 Recognizing NNG PAM

CRISPR/Cas9 for Genome Editing: Progress, Implications and Challenges.

Rationally designed Campylobacter jejuni Cas9 enables efficient gene activation and base editing

FrCas9 is a CRISPR/Cas9 system with high editing efficiency and fidelity

In vivo genome editing in animals using AAV-CRISPR system: applications to translational research of human disease

dCas9-based gene editing for cleavage-free genomic knock-in of long sequences

An engineered Cas12i nuclease that is an efficient genome editing tool in animals and plants

An engineered baculoviral protein and DNA co-delivery system for CRISPR-based mammalian genome editing

Superior Fidelity and Distinct Editing Outcomes of SaCas9 Compared with SpCas9 in Genome Editing.

A Compact Cas9 Ortholog from Staphylococcus Auricularis (sauricas9) Expands the DNA Targeting Scope.

Improving Plant Genome Editing with High-Fidelity Xcas9 and Non-canonical PAM-Targeting Cas9-NG